0423 GMT - Investor confidence in WuXi companies looks stronger ahead of Trump's inauguration, Daiwa analyst Wilfred Yuen says. After the proposed U.S. Biosecure Act, which restricts some Chinese biotech companies from doing business in the U.S., was not enacted under the Biden administration, investors are watching to see what the fate of the legislation or any potential successor will be under Trump, Yuen says. Trump's promise on Sunday to save social media app TikTok from being banned in the U.S. is giving some the impression that he may be more pragmatic in dealing with national security-related issues, he says. WuXi AppTec and WuXi Biologics also gave positive updates last week at a conference, confirming that fundamentals are intact, he adds. WuXi AppTec and WuXi Biologics' shares are up 7.3% and 5.4%, respectively, in Hong Kong. (sherry.qin@wsj.com)
(END) Dow Jones Newswires
January 19, 2025 23:23 ET (04:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。